Vanessa Pacheco

Dr. Vanessa Pacheco


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 July 2023 in Viruses
Verified
Journal Article
Open access
PDF file
VPVanessa Pacheco
Vanessa Pacheco
RGRosane Cuber Guimarães
Rosane Cuber Guimarães
Danielly Corrêa-MoreiraDanielly Corrêa-Moreira
Danielly Corrêa-Moreira
CMCarlos Eduardo Magalhães
Carlos Eduardo Magalhães
DFDouglas Poschinger Figueiredo
Douglas Poschinger Figueiredo
Manoel Marques Evangelista OliveiraManoel Marques Evangelista Oliveira
Manoel Marques Evangelista Oliveira
Objectives: The aim of this study is to evaluate some mechanisms of the immune response of people infected with SARS-CoV-2 in both acute infection and early and late convalescence phases. Methods: This is a cohort study of 70 cases of COVID-19, confirmed by RT-PCR, followed up to 60 days. Plasma Samples and clinical data were. Viral load, blood count, indicators inflammation were the parameters evaluated. Cellular immune response was evaluated by flow cytometry and Luminex immunoassays. Results: In the severe group, hypertension was the only reported comorbidity. Non severe patients have activated memory naive CD4+ T cells. Critically ill patients have central memory CD4+ T cell activation. Severe COVID-19 patients have both central memory and activated effector CD8+ T cells. Non-severe COVID-19 cases showed an increase in IL1β, IL-6, IL-10 and TNF and severely ill patients had higher levels of the cytokines IL-6, IL-10 and CXCL8. Conclusions: The present work showed that different cellular responses are observed according to the COVID-19 severity in patients from Brazil an epicenter the pandemic in South America. Also, we notice that some cytokines can be used as predictive markers for the disease outcome, possibility implementation of strategies effective by health managers.

19 June 2023 in Preprints.org
Verified
Preprint
Open access
PDF file
VPVanessa Pacheco
Vanessa Pacheco
RGRosane Cuber Guimarães
Rosane Cuber Guimarães
Danielly Corrêa-MoreiraDanielly Corrêa-Moreira
Danielly Corrêa-Moreira
CMCarlos Eduardo Magalhães
Carlos Eduardo Magalhães
DFDouglas Poschinger Figueiredo
Douglas Poschinger Figueiredo
Manoel Marques Evangelista OliveiraManoel Marques Evangelista Oliveira
Manoel Marques Evangelista Oliveira
Objectives: The aim of this study is to evaluate some mechanisms of the immune response of people infected with SARS-CoV-2 in both acute infection and early and late convalescence phases. Methods: This is a cohort study of 70 cases of COVID-19, confirmed by RT-PCR, followed up to 60 days. Plasma Samples and clinical data were. Viral load, blood count, indicators inflammation were the parameters evaluated. Cellular immune response was evaluated by flow cytometry and Luminex immunoassays. Results: In the severe group, hypertension was the only reported comorbidity. Non severe patients have activated memory naive CD4+ T cells. Critically ill patients have central memory CD4+ T cell activation. Severe COVIS-19 patients have both central memory TCD8+ T cells and activated effector TCD8+ cells. Non-severe COVID-19 cases showed an increase in IL1β, IL-6, IL-10 and TNF and severely ill patients had higher levels of the cytokines IL-6, IL-10 and CXCL8.Conclusion: The present work showed that different cellular responses are observed according to the COVID-19 severity in patients from Brazil an epicenter the pandemic in South America. Also, we notice that some cytokines can be used as predictive markers for the disease outcome, possibility implementation of strategies effective by health managers.